Sex and gender differences in autoimmune diseases

Sex and Gender Aspects in Clinical Medicine

Volumn , Issue , 2013, Pages 101-124

  Zandman Goddard, Gisele ^a,b   Peeva, Elena ^c   Rozman, Ziv ^a   Ben Zvi, Ilan ^d   Langevitz, Pnina ^b,d   Shvartser, Yulia ^d   Amital, Daniela ^e   Amital, Howard ^b,d   Kivity, Shaye ^d   Lidar, Merav ^b,d   Orbach, Hedi ^a   Shoenfeld, Yehuda ^b,d  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

^e NESS ZIONA MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926398434     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-85729-832-4_8     Document Type: Chapter

References (227)

1. Aharon A, Zandman-Goddard G, Shoenfeld Y. Autoimmune multiorgan involvement in elderly men is it SLE? Clin Rheumatol. 1994;13(4):631-634.
2. Bijl M, Reefman E, Limburg PC, et al. Inflammatory clearance of apoptotic cells after UVB challenge. Autoimmunity. 2007;40(4):244-248.
3. Cooper GS, Wither J, Bernatsky S, et al. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology (Oxford). 2010;49(11):2172-2180.
4. Lipworth L, Tarone RE, McLaughlin JK. Silicone breast implants and connective tissue disease: an updated review of the epidemiologic evidence. Ann Plast Surg. 2004;52(6):598-601.
5. Oliver JE, Silman AJ. Why are women predisposed to autoimmune rheumatic diseases? Arthritis Res Ther. 2009;11(5):252.
6. Wang J, Kay AB, Fletcher J, et al. Is lipstick associated with the development of systemic lupus erythematosus (SLE)? Clin Rheumatol. 2008;27(9):1183-1187.
7. Zandman-Goddard G, Blank M, Ehrenfeld M, et al. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol. 1999;26(1):73-77.
8. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34(3):J258-J265.
9. Saha S, Tieng A, Pepeljugoski KP, et al. Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models. Clin Rev Allergy Immunol. 2011;40(1):8-15.
10. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender influences SLE-immune cells, genetics, experimental models and lupus patients. Clin Exp Rheumatol. 2010;28(3):297-299.
11. Hughes GC, Martin D, Zhang K, et al. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Arthritis Rheum. 2009;60(6):1775-1784.
12. Jiang B, Sun L, Hao S, et al. Estrogen modulates bone marrowderived DCs in SLE murine model-(NZB x NZW) F1 female mice. Immunol Invest. 2008;37(3):227-243.
13. Panchanathan R, Shen H, Bupp MG, et al. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol. 2009;183(11):7031-7038.
14. Walters E, Rider V, Abdou NI, et al. Estradiol targets T cell signaling pathways in human systemic lupus. Clin Immunol. 2009;133(3):428-436.
15. Sequeira JF, Keser G, Greenstein B, et al. Systemic lupus erythematosus: sex hormones in male patients. Lupus. 1993;2(5):315-317.
16. Scofield RH, Bruner GR, Namjou B, et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum. 2008;58(8):2511-2517.
17. Rubtsov AV, Rubtsova K, Kappler JW, et al. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev. 2010;9(7):494-498.
18. Invernizzi P, Miozzo M, Oertelt-Prigione S, et al. X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci. 2007;1110:84-91.
19. Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol. 2008;22(5):913-922.
20. Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60(5):1484-1487.
21. Yacoub Wasef SZ. Gender differences in systemic lupus erythematosus. Gend Med. 2004;1(12):7.
22. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases - 2008. Isr Med Assoc J. 2008;10(1):8-12.
23. Costenbader KH, Feskanich D, Stampfer MJ, et al. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 2007;56(4):1251-1262.
24. Shabanova SS, Ananieva LP, Alekberova ZS, et al. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2008;26(3):436-441.
25. Askanase AD. Estrogen therapy in systemic lupus erythematosus. Treat Endocrinol. 2004;3(1):19-26.
26. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142(12 Pt 1):953-962.
27. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353(24):2539-2549.
28. Molad Y. Systemic lupus erythematosus and pregnancy. Curr Opin Obstet Gynecol. 2006;18(6):613-617.
29. Jara LJ, Cruz-Cruz P, Saavedra MA, et al. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann N Y Acad Sci. 2007;1110:297-304.
30. Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev. 2007;6(8):537-542.
31. Lu LJ, Wallace DJ, Ishimori ML, et al. Review: male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus. 2010;19(2):119-129.
32. Andrade RM, Alarcon GS, Fernandez M, et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 2007;56(2):622-630.
33. Prete PE, Majlessi A, Gilman S, et al. Systemic lupus erythematosus in men: a retrospective analysis in a Veterans Administration Healthcare System population. J Clin Rheumatol. 2001;7(3):142-150.
34. Urowitz MB, Gladman D, Ibanez D, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62(6):881-887.
35. Chiu YM, Lai CH. Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus. 2010;19(10):1250-1255.
36. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23(5):581-590.
37. Chifflot H, Fautrel B, Sordet C, et al. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37(4):223-235.
38. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778-799.
39. Murata H, Nakauchi H, Sumida T. Microchimerism in Japanese women patients with systemic sclerosis. Lancet. 1999;354(9174):220.
40. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2(9):777-780.
41. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev. 2007;6(6):366-372.
42. Pagalavan L, Ong SG. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre. Med J Malaysia. 2007;62(2):117-121.
43. Flavahan NA, Flavahan S, Liu Q, et al. Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma. Arthritis Rheum. 2000;43(8):1886-1890.
44. Levin ER. Endothelins. N Engl J Med. 1995;333(6):356-363.
45. Pearson JD. The endothelium: its role in scleroderma. Ann Rheum Dis. 1991;50(Suppl 4):866-871.
46. Rudnicka L, Majewski S, Blaszczyk M, et al. Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1992;35(7):771-775.
47. Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med. 1997;185(1):71-79.
48. Henault J, Robitaille G, Senecal JL, et al. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum. 2006;54(3):963-973.
49. Dieude P, Guedj M, Wipff J, et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a metaanalysis. Arthritis Rheum. 2008;58(7):2183-2188.
50. Gourh P, Tan FK, Assassi S, et al. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum. 2006;54(12):3945-3953.
51. Chen Y, Shi-Wen X, Van Beek J, et al. Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am J Pathol. 2005;167(6):1699-1711.
52. Gardner H, Shearstone JR, Bandaru R, et al. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum. 2006;54(6):1961-1973.
53. Shi-Wen X, Panesar M, Vancheeswaran R, et al. Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen. Arthritis Rheum. 1994;37(11):1689-1697.
54. Hoshi M, Yasuoka H, Kuwana M. Estrogen receptor gene polymorphisms in Japanese patients with systemic sclerosis. Clin Exp Rheumatol. 2008;26(5):914-917.
55. Beretta L, Caronni M, Scorza R. Systemic sclerosis following oral contraception. Clin Rheumatol. 2005;24(3):316-317.
56. Ozbalkan Z, Bagislar S, Kiraz S, et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum. 2005;52(5):1564-1570.
57. McCombe PA, Greer JM, Mackay IR. Sexual dimorphism in autoimmune disease. Curr Mol Med. 2009;9(9):1058-1079.
58. Ozcelik T. X chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol. 2008;34(3):348-351.
59. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med. 1998;338(17):1186-1191.
60. Pope JE. Treatment of systemic sclerosis. Rheum Dis Clin North Am. 1996;22(4):893-907.
61. Sullivan KM, Witherspoon RP, Storb R, et al. Alternatingday cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood. 1988;72(2):555-561.
62. Bonneterre V, Faisandier L, Bicout D, et al. Programmed health surveillance and detection of emerging diseases in occupational health: contribution of the French national occupational disease surveillance and prevention network (RNV3P). Occup Environ Med. 2010;67(3):178-186.
63. Lacey JV Jr, Garabrant DH, Laing TJ, et al. Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol. 1999;149(8):761-770.
64. Nietert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998;41(6):1111-1118.
65. Kettaneh A, Al Moufti O, Tiev KP, et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol. 2007;34(1):97-103.
66. Maitre A, Hours M, Bonneterre V, et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol. 2004;31(12):2395-2401.
67. Le Roy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202-205.
68. Carreira PE, Carmona L, Joven BE, et al. Gender differences in early systemic sclerosis patients: a report from the EULAR database. Ann Rheum Dis. 2009;68(Suppl 3):96.
69. Hudson M, Thombs B, Baron M. Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum. 2009;61(2):274-278.
70. Tager RE, Tikly M. Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans. Rheumatology (Oxford). 1999;38(5):397-400.
71. Walker UA, Tyndall A, Ruszat R. Erectile dysfunction in systemic sclerosis. Ann Rheum Dis. 2009;68(7):1083-1085.
72. Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis. 2010;69(1):218-221.
73. Silman AJ, Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis. 1988;47(6):441-444.
74. Ibba-Manneschi L, Manetti M, Milia AF, et al. Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. Ann Rheum Dis. 2010;69(2):458-461.
75. Sampaio-Barros PD, Samara AM, Marques Neto JF. Gynaecologic history in systemic sclerosis. Clin Rheumatol. 2000;19(3):184-187.
76. Miniati I, Guiducci S, Mecacci F, et al. Pregnancy in systemic sclerosis. Rheumatology (Oxford). 2008;47(Suppl 3): iii16-iii18.
77. Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y. New therapeutic strategies for systemic sclerosis - a critical analysis of the literature. Clin Dev Immunol. 2005;12(3):165-173.
78. Kaye SA, Lim SG, Taylor M, et al. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol. 1995;34(3):265.
79. Chung L, Krishnan E, Chakravarty EF. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. Rheumatology (Oxford). 2007;46(12):1808-1813.
80. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39(4):269-277.
81. Perez-Bocanegra C, Solans-Laque R, Simeon-Aznar CP, et al. Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology (Oxford). 2010;49(6):1112-1117.
82. Binard A, Devauchelle-Pensec V, Fautrel B, et al. Epidemiology of Sjogren's syndrome: where are we now? Clin Exp Rheumatol. 2007;25(1):1-4.
83. Theander E, Jacobsson LT. Relationship of Sjogren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am. 2008;34(4):935-947. viii-ix.
84. Priori R, Medda E, Conti F, et al. Risk factors for Sjogren's syndrome: a case-control study. Clin Exp Rheumatol. 2007;25(3):378-384.
85. Nandula SR, Amarnath S, Molinolo A, et al. Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands. Arthritis Rheum. 2007;56(6):1798-1805.
86. Nguyen C, Singson E, Kim JY, et al. Sjogren's syndromelike disease of C57BL/6. NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus. Scand J Immunol. 2006;64(3):295-307.
87. Sullivan DA, Wickham LA, Rocha EM, et al. Androgens and dry eye in Sjogren's syndrome. Ann N Y Acad Sci. 1999;876:312-324.
88. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen-deficient? J Rheumatol. 2003;30(11):2413-2419.
89. Valtysdottir ST, Wide L, Hallgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol. 2001;28(6):1259-1265.
90. Porola P, Laine M, Virtanen I, et al. Androgens and integrins in salivary glands in Sjogren's syndrome. J Rheumatol. 2010;37(6):1181-1187.
91. Porola P, Virkki L, Przybyla BD, et al. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjogren's syndrome. J Rheumatol. 2008;35(11):2229-2235.
92. Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci. 2002;966:211-222.
93. El Miedany YM, Ahmed I, Moustafa H, et al. Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation? Joint Bone Spine. 2004;71:203-208.
94. Gutierrez MA, Anaya JM, Scopelitis E, et al. Hyperprolactinaemia in primary Sjogren's syndrome. Ann Rheum Dis. 1994;53(6):425.
95. Haga HJ, Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome. J Rheumatol. 1999;26(6):1291-1295.
96. Buskila D, Berezin M, Gur H, et al. Autoantibody profile in the sera of women with hyperprolactinemia. J Autoimmun. 1995;8(3):415-424.
97. Steinfeld S, Maho A, Chaboteaux C, et al. Prolactin upregulates cathepsin B and D expression in minor salivary glands of patients with Sjogren's syndrome. Lab Invest. 2000;80(11):1711-1720.
98. Steinfeld S, Rommes S, Francois C, et al. Big prolactin 60 kDa is overexpressed in salivary glandular epithelial cells from patients with Sjogren's syndrome. Lab Invest. 2000;80(2):239-247.
99. Carlsten H, Nilsson N, Jonsson R, et al. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol. 1992;144(1):190-202.
100. Ishimaru N, Saegusa K, Yanagi K, et al. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through fas-mediated apoptosis. Am J Pathol. 1999;155(1):173-181.
101. Ishimaru N, Arakaki R, Watanabe M, et al. Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen-deficient mice of healthy background. Am J Pathol. 2003;163(4):1481-1490.
102. Shim GJ, Warner M, Kim HJ, et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc Natl Acad Sci USA. 2004;101(34):12628-12633.
103. Laroche M, Borg S, Lassoued S, et al. Joint pain with aromatase inhibitors: abnormal frequency of Sjogren's syndrome. J Rheumatol. 2007;34(11):2259-2263.
104. Nagler RM, Pollack S. Sjogren's syndrome induced by estrogen therapy. Semin Arthritis Rheum. 2000;30(3):209-214.
105. Ahmed SA, Aufdemorte TB, Chen JR, et al. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. J Autoimmun. 1989;2(4):543-552.
106. Brennan MT, Fox PC. Sex differences in primary Sjogren's syndrome. J Rheumatol. 1999;26(11):2373-2376.
107. Molina R, Provost TT, Arnett FC, et al. Primary Sjogren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med. 1986;80(1):23-31.
108. Cervera R, Font J, Ramos-Casals M, et al. Primary Sjogren's syndrome in men: clinical and immunological characteristics. Lupus. 2000;9(1):61-64.
109. Horvath IF, Szodoray P, Zeher M. Primary Sjogren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol. 2008;27(12):1479-1483.
110. Pillemer SR, Brennan MT, Sankar V, et al. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome. Arthritis Rheum. 2004;51(4):601-604.
111. Hartkamp A, Geenen R, Godaert GL, et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial. Ann Rheum Dis. 2008;67(1):91-97.
112. Virkki LM, Porola P, Forsblad-d'Elia H, et al. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjogren's syndrome. Arthritis Care Res (Hoboken). 2010;62(1):118-124.
113. Forsblad-d'Elia H, Carlsten H, Labrie F, et al. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab. 2009;94(6):2044-2051.
114. Ansell P, Simpson J, Lightfoot T, et al. Non-Hodgkin lymphoma and autoimmunity: does gender matter? Int J Cancer. Sep. 17.
115. Wolfe F. New American College of Rheumatology criteria for fibromyalgia: a twenty-year journey. Arthritis Care Res (Hoboken). 2010;62(5):583-584.
116. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-172.
117. Kilbom AM. Work-related musculoskeletal disorders. In: Kilbom AM, ed. Women's Health at Work. Solna: National Institute of Working Life; 2010:203-227.
118. Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19-28.
119. Kato K, Sullivan PF, Evengard B, et al. Importance of genetic influences on chronic widespread pain. Arthritis Rheum. 2006;54(5):1682-1686.
120. Vishne T, Fostick L, Silberman A, et al. Fibromyalgia among major depression disorder females compared to males. Rheumatol Int. 2008;28(9):831-836.
121. Borg K, Hensing G, Alexanderson K. Predictive factors for disability pension - an 11-year follow up of young persons on sick leave due to neck, shoulder, or back diagnoses. Scand J Public Health. 2001;29(2):104-112.
122. Munce SE, Stewart DE. Gender differences in depression and chronic pain conditions in a national epidemiologic survey. Psychosomatics. 2007;48(5):394-399.
123. Henriksson C, Gundmark I, Bengtsson A, et al. Living with fibromyalgia. Consequences for everyday life. Clin J Pain. 1992;8(2):138-144.
124. Clauw DJ. Fibromyalgia: an overview. Am J Med. 2009;122(12 Suppl):S3-S13.
125. Anderberg UM, Liu Z, Berglund L, et al. Plasma levels on nociceptin in female fibromyalgia syndrome patients. Z Rheumatol. 1998;57(Suppl 2):77-80.
126. Hellstrom B, Anderberg UM. Pain perception across the menstrual cycle phases in women with chronic pain. Percept Mot Skills. 2003;96(1):201-211.
127. Macfarlane TV, Blinkhorn A, Worthington HV, et al. Sex hormonal factors and chronic widespread pain: a population study among women. Rheumatology (Oxford). 2002;41(4):454-457.
128. Amital D, Fostick L, Polliack ML, et al. Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? J Psychosom Res. 2006;61(5):663-669.
129. Cohen H, Neumann L, Haiman Y, et al. Prevalence of posttraumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum. 2002;32(1):38-50.
130. Smith WR, Strachan ED, Buchwald D. Coping, self-efficacy and psychiatric history in patients with both chronic widespread pain and chronic fatigue. Gen Hosp Psychiatry. 2009;31(4):347-352.
131. Buskila D, Neumann L, Alhoashle A, et al. Fibromyalgia syndrome in men. Semin Arthritis Rheum. 2000;30(1):47-51.
132. Hirsh AT, Waxenberg LB, Atchison JW, et al. Evidence for sex differences in the relationships of pain, mood, and disability. J Pain. 2006;7(8):592-601.
133. Hooten WM, Townsend CO, Decker PA. Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation. Pain Med. 2007;8(8):624-632.
134. Dannecker EA, Knoll V, Robinson ME. Sex differences in muscle pain: self-care behaviors and effects on daily activities. J Pain. 2008;9(3):200-209.
135. Markkula R, Jarvinen P, Leino-Arjas P, et al. Clustering of symptoms associated with fibromyalgia in a Finnish Twin Cohort. Eur J Pain. 2009;13(7):744-750.
136. Yunus MB, Celiker R, Aldag JC. Fibromyalgia in men: comparison of psychological features with women. J Rheumatol. 2004;31(12):2464-2467.
137. Aggarwal VR, McBeth J, Zakrzewska JM, et al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol. 2006;35(2):468-476.
138. Katz JD, Mamyrova G, Guzhva O, et al. Gender bias in diagnosing fibromyalgia. Gend Med. 2010;7(1):19-27.
139. Garcia-Campayo J, Magdalena J, Magallon R, et al. A meta-analysis of the efficacy of fibromyalgia treatment according to level of care. Arthritis Res Ther. 2008;10(4):R81.
140. Jawaheer D, Lum RF, Gregersen PK, et al. Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheum. 2006;54(10):3087-3094.
141. Sokka T, Toloza S, Cutolo M, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 2009;11(1):R7.
142. Jawaheer D, Linos A, Worthington JW, et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence and mortality. Am J Epidemiol. 1980;111:87-98.
143. Wilder RL. Hormones and autoimmunity: animal models of arthritis. Baillieres Clin Rheumatol. 1996;10(2):259-271.
144. Wolfe AM, Kellgren JH, Masi AT. The epidemiology of rheumatoid arthritis: a review. II. Incidence and diagnostic criteria. Bull Rheum Dis. 1968;19(3):524-529.
145. Tengstrand B, Ahlmen M, Hafstrom I. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol. 2004;31(2):214-222.
146. Wilder RL. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J Rheumatol Suppl. 1996;44:10-12.
147. Weyand CM, Schmidt D, Wagner U, et al. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 1998;41(5):817-822.
148. Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70-81.
149. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res Ther. 2003;5(3):R158-R162.
150. Oka M. Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann Rheum Dis. 1953;12(3):227-229.
151. Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum. 1994;37(6):808-813.
152. Kanik KS, Wilder RL. Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy. Rheum Dis Clin North Am. 2000;26(4):805-823.
153. Elenkov IJ, Hoffman J, Wilder RL. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol Med Today. 1997;3(9):379-383.
154. Brennan P, Bankhead C, Silman A, et al. Oral contraceptives and rheumatoid arthritis: results from a primary carebased incident case-control study. Semin Arthritis Rheum. 1997;26(6):817-823.
155. Kuiper S, Van Gestel AM, Swinkels HL, et al. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol. 2001;28(8):1809-1816.
156. Tengstrand B, Carlstrom K, Fellander-Tsai L, et al. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol. 2003;30(11):2338-2343.
157. Cutolo M, Accardo S. Sex hormones, HLA and rheumatoid arthritis. Clin Exp Rheumatol. 1991;9(6):641-646.
158. Yamasaki D, Enokida M, Okano T, et al. Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis. Bone. 2001;28(6):634-640.
159. Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol Rev. 2005;208:194-206.
160. Masi AT, Feigenbaum SL, Chatterton RT. Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. Semin Arthritis Rheum. 1995;25(1):1-27.
161. ∗ 0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol. 1995;22(6):1032-1036.
162. Meyer JM, Han J, Singh R, et al. Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis. Am J Hum Genet. 1996;58(2):371-383.
163. De Vries N, Tak PP, Tijssen H, et al. Female sex increases risk for rheumatoid arthritis only in individuals encoding low-risk HLA-DRB1 alleles. Arthritis Rheum. 2003;48(6):1762-1763.
164. Jawaheer D, Li W, Graham RR, et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet. 2002;71(3):585-594.
165. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest. 1992;89(6):2033-2039.
166. Kaarela K. Prognostic factors and diagnostic criteria in early rheumatoid arthritis. Scand J Rheumatol Suppl. 1985;57:1-54.
167. Makisara GL, Makisara P. Prognosis of functional capacity and work capacity in rheumatoid arthritis. Clin Rheumatol. 1982;1(2):117-125.
168. Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventyfive rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984;27(8):864-872.
169. Scott DL, Grindulis KA, Struthers GR, et al. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis. 1984;43(1):8-17.
170. Yelin E, Meenan R, Nevitt M, et al. Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med. 1980;93(4):551-556.
171. Bjork M, Thyberg I, Haglund L, et al. Hand function in women and men with early rheumatoid arthritis. A prospective study over three years (the Swedish TIRA project). Scand J Rheumatol. 2006;35(1):15-19.
172. Da Silva JA, Hall GM. The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol. 1992;6(1):196-219.
173. Forslind K, Hafstrom I, Ahlmen M, et al. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis. 2007;66(1):46-52.
174. Symmons DP. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol. 2002;16(5):707-722.
175. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16(4):266-275.
176. Sherrer YS, Bloch DA, Mitchell DM, et al. Disability in rheumatoid arthritis: comparison of prognostic factors across three populations. J Rheumatol. 1987;14(4):705-709.
177. Puolakka K, Kautiainen H, Pekurinen M, et al. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis. 2006;65(7):899-904.
178. Ahlmen M, Svensson B, Albertsson K, et al. Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann Rheum Dis. 2010;69(1):230-233.
179. Leeb BF, Haindl PM, Maktari A, et al. Disease activity score-28 values differ considerably depending on patient's pain perception and sex. J Rheumatol. 2007;34(12):2382-2387.
180. Rintelen B, Haindl PM, Maktari A, et al. SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender. Scand J Rheumatol. 2008;37(6):410-413.
181. Doeglas D, Krol B, Guillemin F, et al. The assessment of functional status in rheumatoid arthritis: a cross cultural, longitudinal comparison of the Health Assessment Questionnaire and the Groningen Activity Restriction Scale. J Rheumatol. 1995;22(10):1834-1843.
182. Deighton CM, Surtees D, Walker DJ. Influence of the severity of rheumatoid arthritis on sex differences in health assessment questionnaire scores. Ann Rheum Dis. 1992;51(4):473-475.
183. West E, Jonsson SW. Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36. Clin Rheumatol. 2005;24(2):117-122.
184. Van Middendorp H, Geenen R, Sorbi MJ, et al. Gender differences in emotion regulation and relationships with perceived health in patients with rheumatoid arthritis. Women Health. 2005;42(1):75-97.
185. Fifield J, Reisine S, Sheehan TJ, et al. Gender, paid work, and symptoms of emotional distress in rheumatoid arthritis patients. Arthritis Rheum. 1996;39(3):427-435.
186. Karlsson B, Berglin E, Wallberg-Jonsson S. Life satisfaction in early rheumatoid arthritis: a prospective study. Scand J Occup Ther. 2006;13(3):193-199.
187. Lard LR, Huizinga TW, Hazes JM, et al. Delayed referral of female patients with rheumatoid arthritis. J Rheumatol. 2001;28(10):2190-2192.
188. Speerstra F, Van Riel PL, Reekers P, et al. The influence of HLA phenotypes on the response to parenteral gold in rheumatoid arthritis. Tissue Antigens. 1986;28(1):1-7.
189. Alderman AK, Arora AS, Kuhn L, et al. An analysis of women's and men's surgical priorities and willingness to have rheumatoid hand surgery. J Hand Surg Am. 2006;31(9):1447-1453.
190. Atzeni F, Antivalle M, Pallavicini FB, et al. Predicting response to anti-TNF treatment in rheumatoid arthritis patients. Autoimmun Rev. 2009;8(5):431-437.
191. Hyrich KL, Watson KD, Silman AJ, et al. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2006;45(12):1558-1565.
192. Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol. 2007;34(8):1670-1673.
193. Anderson ST. Mortality in rheumatoid arthritis: do age and gender make a difference? Semin Arthritis Rheum. 1996;25(5):291-296.
194. Wallenius M, Skomsvoll JF, Koldingsnes W, et al. Work disability and health-related quality of life in males and females with psoriatic arthritis. Ann Rheum Dis. 2009;68(5):685-689.
195. Kasle S, Wilhelm MS, Zautra AJ. Rheumatoid arthritis patients' perceptions of mutuality in conversations with spouses/partners and their links with psychological and physical health. Arthritis Rheum. 2008;59(7):921-928.
196. Kraaimaat FW, Bakker AH, Janssen E, et al. Intrusiveness of rheumatoid arthritis on sexuality in male and female patients living with a spouse. Arthritis Care Res. 1996;9(2):120-125.
197. Calin A. Ankylosing spondylitis. In: Maddison PJ, Isenberg DA, Woo P, et al., eds. Oxford Textbook of Rheumatology. 2nd ed. Oxford: Oxford University Press; 1998:1058-1070.
198. West HF. Aetiology of ankylosing spondylitis. Ann Rheum Dis. 1949;8(2):143-148.
199. Will R, Edmunds L, Elswood J, et al. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol. 1990;17(12):1649-1652.
200. Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum. 1993;22(5):319-334.
201. Brown MA, Pile KD, Kennedy LG, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis. 1996;55(4):268-270.
202. Calin A, Marder A, Becks E, et al. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum. 1983;26(12):1460-1464.
203. Van Der Linden SM, Valkenburg HA, De Jongh BM, et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 1984;27(3):241-249.
204. Calin A, Brophy S, Blake D. Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet. 1999;354(9191):1687-1690.
205. Brophy S, Taylor G, Blake D, et al. The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis. J Rheumatol. 2003;30(9):2054-2058.
206. Hoyle E, Laval SH, Calin A, et al. The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum. 2000;43(6):1353-1355.
207. Zhang G, Luo J, Bruckel J, et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 2004;50(7):2246-2254.
208. Lee W, Reveille JD, Davis JC Jr, et al. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007;66(5):633-638.
209. Lee W, Reveille JD, Weisman MH. Women with ankylosing spondylitis: a review. Arthritis Rheum. 2008;59(3):449-454.
210. Jimenez-Balderas FJ, Tapia-Serrano R, Madero-Cervera JI, et al. Ovarian function studies in active ankylosing spondylitis in women. Clinical response to estrogen therapy. J Rheumatol. 1990;17(4):497-502.
211. Miyamoto N, Mandai M, Suzuma I, et al. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol. 1999;163(1):374-379.
212. Tsui HW, Inman RD, Paterson AD, et al. ANKH variants associated with ankylosing spondylitis: gender differences. Arthritis Res Ther. 2005;7(3):R513-R525.
213. Gran JT, Ostensen M, Husby G. A clinical comparison between males and females with ankylosing spondylitis. J Rheumatol. 1985;12(1):126-129.
214. Calin A, Mackay K, Santos H, et al. A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol. 1999;26(4):988-992.
215. Braunstein EM, Martel W, Moidel R. Ankylosing spondylitis in men and women: a clinical and radiographic comparison. Radiology. 1982;144(1):91-94.
216. Eustace S, Coughlan RJ, McCarthy C. Ankylosing spondylitis. A comparison of clinical and radiographic features in men and women. Ir Med J. 1993;86(4):120-122.
217. Barlow JH, Macey SJ, Struthers GR. Gender, depression, and ankylosing spondylitis. Arthritis Care Res. 1993;6(1):45-51.
218. Hultgren S, Broman JE, Gudbjornsson B, et al. Sleep disturbances in outpatients with ankylosing spondylitisa questionnaire study with gender implications. Scand J Rheumatol. 2000;29(6):365-369.
219. Aloush V, Ablin JN, Reitblat T, et al. Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int. 2007;27(9):865-868.
220. Jung YO, Kim I, Kim S, et al. Clinical and radiographic features of adult-onset ankylosing spondylitis in Korean patients: comparisons between males and females. J Korean Med Sci. 2010;25(4):532-535.
221. Jimenez-Balderas FJ, Mintz G. Ankylosing spondylitis: clinical course in women and men. J Rheumatol. 1993;20(12):2069-2072.
222. Isohisa I, Tanaka M, Ishida H. Sex influence on the cardiac complication of ankylosing spondylitis - analysis of 95 cases of ankylosing spondylitis including our case. Kokyu To Junkan. 1990;38(1):53-58.
223. Valkenborgh P, Dequeker J, Gielen F, et al. Arthritis and heart lesions. A study of 25 cases with pericarditis or valvular lesions associated to inflammatory joint disease. Acta Cardiol. 1976;31(4):269-276.
224. Hill HF, Hill AG, Bodmer JG. Clinical diagnosis of ankylosing spondylitis in women and relation to presence of HLA-B27. Ann Rheum Dis. 1976;35(3):267-270.
225. Boyer GS, Templin DW, Bowler A, et al. A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us? Arch Intern Med. 1997;157(18):2111-2117.
226. Boyer GS, Templin DW, Bowler A, et al. Spondyloarthropathy in the community: differences in severity and disease expression in Alaskan Eskimo men and women. J Rheumatol. 2000;27(1):170-176.
227. Inman RD, Davis JC Jr, Heijde D, et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum. 2008;58(11):3402-3412.